ASCT2 (SLC1A5, System A Amino Acid Transporter 2) is a sodium-dependent neutral amino acid transporter that plays critical roles in cellular metabolism, particularly in the exchange of amino acids required for tumor cell growth, neuronal function, and immune responses. ASCT2 is a member of the SLC1 (solute carrier family 1) transporter family and functions as a high-affinity transporter for glutamine, serine, alanine, cysteine, and other small neutral amino acids. In the central nervous system, ASCT2 is essential for maintaining glutamine cycles between astrocytes and neurons, with significant implications for neurotransmitter biosynthesis and neuronal metabolism.
ASCT2 is a multipass transmembrane protein with the following structural features:
- Primary Structure: 541 amino acids, molecular weight ~56 kDa
- Transmembrane Architecture: 8-10 transmembrane alpha-helical domains
- Aspartate Residue (D455): Critical for substrate binding and transport kinetics
- Oligomeric State: Functions as a homotrimer in the plasma membrane
ASCT2 operates as an obligatory exchange transporter:
- Stoichiometry: Na+:substrate = 1:1
- Transport Mode: Obligatory exchange (antiport)
- Direction: Typically imports neutral amino acids in exchange for intracellular substrates
- Electrogenicity: Net negative charge per transport cycle
ASCT2 Transport Mechanism
┌──────────────────────────────────────┐
│ Cell Membrane │
│ ┌─────────┐ ┌─────────────┐ │
│ │ Extracel │ │ Intracellular│ │
│ │ lular │◄──────►│ │ │
│ │ │ │ │ │
│ │ Gln, Ser│ │ Internal │ │
│ │ Ala, Cys│ │ amino acids │ │
│ └─────────┘ └─────────────┘ │
│ ↑ │ │
│ └──── Na+ (co-transport)┘ │
└──────────────────────────────────────┘
ASCT2 transports a wide range of neutral amino acids with varying affinities:
| Substrate |
Km (μM) |
Transport Direction |
| Glutamine |
~100 |
Import |
| Serine |
~50 |
Import |
| Alanine |
~200 |
Import |
| Cysteine |
~150 |
Import |
| Threonine |
~100 |
Import |
| Asparagine |
~80 |
Import |
Glutamine Transport and Metabolism:
- Provides glutamine for de novo synthesis of nucleotides and amino acids
- Supports mTORC1 activation through glutamine sensing
- Enables glutathione synthesis through cysteine import
- Regulates intracellular amino acid pools
mTORC1 Activation:
- Glutamine import via ASCT2 is essential for mTORC1 signaling
- Serves as an amino acid sensor for cell growth
- Integrates nutrient signaling with cellular metabolism
Glutathione Synthesis:
- Imports cysteine (rate-limiting precursor)
- Supports antioxidant defense in neurons and glia
- High Expression: Kidney, intestine, liver, placenta
- Brain: Astrocytes and neurons, particularly in glutamatergic neurons
- Immune Cells: Activated T cells and natural killer cells
- Cancer Cells: Frequently upregulated in tumors (Warburg effect)
ASCT2 dysfunction contributes to multiple aspects of AD pathogenesis:
Glutamine Transport Alterations:
- ASCT2 expression is downregulated in AD brain
- Impaired glutamine transport affects neuronal metabolism
- Disrupted glutamate/GABA cycling between astrocytes and neurons
- Altered neurotransmitter precursor availability
Metabolic Dysregulation:
- Reduced mTORC1 signaling in neurons
- Impaired glutathione synthesis increases oxidative stress
- Defective amino acid sensing affects protein synthesis
Therapeutic Implications:
- ASCT2 activators may improve neuronal metabolism
- Glutamine supplementation strategies
- Antioxidant therapies targeting glutathione synthesis
In Parkinson's disease, ASCT2 plays critical roles:
Dopaminergic Neuron Metabolism:
- Glutamine transport is essential for dopamine synthesis
- ASCT2 dysfunction may contribute to energy deficits
- Altered cysteine import affects glutathione maintenance
Neuroinflammation:
- Microglial ASCT2 supports inflammatory responses
- Astrocyte dysfunction in PD
- Glutamine cycle disruption affects neurotransmitter homeostasis
Potential Therapeutic Targets:
- Modulating ASCT2 expression or activity
- Glutamine precursor administration
- Enhancing antioxidant defenses
- Motor neuron metabolism dependence on ASCT2
- Astrocyte support of motor neurons through glutamine transport
- Energy metabolism alterations in ALS
- Altered amino acid transport in HD brain
- Metabolic dysfunction contributing to neuronal loss
- Glutamine cycle abnormalities
| Gene Variant |
Effect |
Disease Association |
| SLC1A5 variants |
Altered transport |
AD, PD risk |
| Expression changes |
Modified glutamine flux |
Neurodegeneration |
| Partner |
Interaction Type |
Functional Consequence |
| mTORC1 |
Amino acid sensing |
Growth signaling |
| Glutamine synthetase |
Substrate supply |
GABA synthesis |
| EAAT1/2 |
Glutamate transport |
Neurotransmission |
| System L (LAT1) |
Exchange partner |
Amino acid balance |
- Astrocytes: High expression, especially in perisynaptic processes
- Neurons: Moderate expression, highest in glutamatergic neurons
- Oligodendrocytes: Lower expression
- Microglia: Variable, increases with activation
- Transcriptional: mTORC1-dependent upregulation
- Post-translational: Phosphorylation affects transport activity
- Substrate-induced: Activity regulated by amino acid levels
- Glutamine analogs: Substrate-based inhibitors
- ASCT2 activators: Enhance transport function
- Amino acid derivatives: Targeted at transport kinetics
- L-Glutamine supplementation: Bypass transport deficits
- N-acetylcysteine: Increase cysteine availability
- Alpha-ketoglutarate: Support metabolic function